Pharmacology News and Research

Latest Pharmacology News and Research

Machine learning helps predict clinical forms of drug-induced cardiotoxicity

We announce the publication of a new research paper titled 'Dual transcriptomic and molecular machine learning predicts all major clinical forms of drug cardiotoxicity' in Frontiers in Pharmacology.

9 Jun 2020

Virginia Tech researcher develops new ‘fat burning’ molecule with potential to treat obesity

Obesity affects more than 40 percent of adults in the United States and 13 percent of the global population.

8 Jun 2020

UTHSC researchers receive NIH award for opioid addiction studies

A team of University of Tennessee Health Science Center researchers in the College of Medicine recently received a National Institutes of Health award to study how genetic differences may explain why some people are more susceptible to opioid addiction than others.

5 Jun 2020

Study: Daily aspirin could be a killer for some, rather than a cure

Daily aspirin could be a killer for some, rather than a cure, according to a new study.

5 Jun 2020

Breakthrough discovery could lead to treatment of Fragile X syndrome

Scientists at the Hotchkiss Brain Institute, Alberta Children's Hospital Research Institute, and Owerko Centre at UCalgary's Cumming School of Medicine have made a breakthrough discovery that could lead to treatment of Fragile X syndrome, the leading genetic cause of Autism Spectrum Disorder.

2 Jun 2020

Researchers develop new method to measure hydroxychloroquine levels in SLE patients

Researchers at Uppsala University and Uppsala University Hospital have developed a new method to measure levels of the medication hydroxychloroquine in patients with rheumatic disease systemic lupus erythematosus (SLE).

1 Jun 2020

Northern Health Science Alliance appoints new life science leaders

THE Northern Health Science Alliance today welcomes three new directors to take forward the organization into the next stage of its development as a world-leading cluster organization across the North’s life sciences.

30 May 2020

Assessing treatment for acute chloroquine poisoning

Research by Bangor University’s Professor Dyfrig Hughes has provided important evidence on the safety of treatments that are being tested for use in COVID-19.

30 May 2020

New book series brings updated reviews on diabetes and obesity

Frontiers in Clinical Drug Research - Diabetes and Obesity is a book series that brings updated reviews to readers interested in advances in the development of pharmaceutical agents for the treatment of two metabolic diseases - diabetes and obesity.

27 May 2020

Genetic discoveries show promise for developing new treatment targets for schizophrenia

In recent years, genome-wide association studies (GWAS) have identified many different genetic variants associated with schizophrenia.

22 May 2020

Novel molecular structures developed for desired transcriptional response

Insilico Medicine announces the publication of a new research paper titled "Molecular Generation for Desired Transcriptome Changes With Adversarial Autoencoders" in Frontiers in Pharmacology

20 May 2020

Chemicals found in consumer products could contribute to onset of lipid-related diseases

Chemical compounds found in many consumer products could be major contributors to the onset of lipid-related diseases, such as obesity, in humans, according to a Baylor University study.

19 May 2020

Phase IIB clinical trial initiated for treating hepatitis B-associated liver cancer

The first patients have been dosed in a multi-regional Phase IIB randomized, placebo-controlled clinical trial for the treatment of hepatitis B-associated liver cancer.

19 May 2020

A new tool to study and map the intricacies of intercellular signaling

How do cells move? Why do they move? Why do some cancer cells move slowly while others move quickly, causing a cancerous tumor to metastasize and become much more difficult to treat effectively?

18 May 2020

Specific immune cells induced by vaccination are early indicators of vaccine efficacy

Ludwig-Maximilians-Universität in Munich researchers have shown that a specific class of immune cells in the blood induced by vaccination is an earlier indicator of vaccine efficacy than conventional tests for neutralizing antibodies.

15 May 2020

Precision medicine can determine the best drug treatment for severe heart disease

Is personalized medicine cost-effective? University of Alabama at Birmingham researcher Nita Limdi, Pharm.D., Ph.D., and colleagues across the United States have answered that question for one medical treatment.

15 May 2020

Using supercomputers to screen drugs for deadly heart arrhythmias

Death from sudden cardiac arrest makes headlines when it strikes athletes. But it also causes the most deaths by natural causes in the U.S. estimated at 325,000 per year.

14 May 2020

I-ACT for Children's COVID-19 Emergency Access Program launched to accelerate pediatric trials

As the number of children with severe COVID-19 illness grows, there is increasing urgency to ensure that potential treatments and vaccines are tested for safety and efficacy in children.

14 May 2020

Study explores whether senicapoc drug can mitigate lung damage in COVID-19 patients

Scientists around the globe are working to identify approved and investigational drugs that can be repurposed to treat COVID-19.

13 May 2020

Finding new therapeutic strategies for aggressive T-cell acute lymphoblastic leukemia

Aiming to identify new therapeutic strategies for the aggressive hematological disease T-cell acute lymphoblastic leukemia (T-ALL), Rutgers Cancer Institute of New Jersey resident researcher Daniel Herranz Benito, PhD, along with collaborators from Princeton University, found a new drug that has therapeutic effect against T-ALL by inhibiting SHMT and is complementary to standard-of-care treatment.

12 May 2020

Pharmacology News and Research

Latest Pharmacology News and Research

Machine learning helps predict clinical forms of drug-induced cardiotoxicity

Virginia Tech researcher develops new ‘fat burning’ molecule with potential to treat obesity

UTHSC researchers receive NIH award for opioid addiction studies

Study: Daily aspirin could be a killer for some, rather than a cure

Breakthrough discovery could lead to treatment of Fragile X syndrome

Researchers develop new method to measure hydroxychloroquine levels in SLE patients

Northern Health Science Alliance appoints new life science leaders

Assessing treatment for acute chloroquine poisoning

New book series brings updated reviews on diabetes and obesity

Genetic discoveries show promise for developing new treatment targets for schizophrenia

Novel molecular structures developed for desired transcriptional response

Chemicals found in consumer products could contribute to onset of lipid-related diseases

Phase IIB clinical trial initiated for treating hepatitis B-associated liver cancer

A new tool to study and map the intricacies of intercellular signaling

Specific immune cells induced by vaccination are early indicators of vaccine efficacy

Precision medicine can determine the best drug treatment for severe heart disease

Using supercomputers to screen drugs for deadly heart arrhythmias

I-ACT for Children's COVID-19 Emergency Access Program launched to accelerate pediatric trials

Study explores whether senicapoc drug can mitigate lung damage in COVID-19 patients

Finding new therapeutic strategies for aggressive T-cell acute lymphoblastic leukemia

Pittcon Highlights: Pharmaceutical & Biologic eBook

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Pharmacology News and Research

Latest Pharmacology News and Research

Pittcon Highlights: Pharmaceutical & Biologic eBook

Leveraging the power of automation to boost research

Automating research - solutions and best practices

How can microdialysis benefit drug development

Newsletters you may be interested in